The University of Chicago Header Logo

Connection

Michael Vannier to Camptothecin

This is a "connection" page, showing publications Michael Vannier has written about Camptothecin.
Connection Strength

0.032
  1. A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma. Pancreas. 2016 Mar; 45(3):370-5.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.